Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/27781
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | Mhaskar, Prashant | - |
dc.contributor.author | Sarna, Samardeepsingh | - |
dc.date.accessioned | 2022-09-02T19:32:57Z | - |
dc.date.available | 2022-09-02T19:32:57Z | - |
dc.date.issued | 2022-11 | - |
dc.identifier.uri | http://hdl.handle.net/11375/27781 | - |
dc.description.abstract | This thesis focuses on data-driven modeling and model predictive control for a monoclonal antibody process. The process uses live cell cultures such as Chinese Hamster Ovary (CHO) cells and thus needs special consideration. With the trend in the industry to move towards perfusion processes which are continuous allowing better productivity, advanced process control would play a vital role. Model Predictive Control (MPC) requires a suitable model to optimally control the process. First principles models for such live cell processes are complex and unsuitable for direct use in MPC. In this work, we focus on data-driven modeling given its suitability for use in control. The data-driven model is eventually also incorporated with some first principles knowledge for better performance and robustness. Data-driven modelling requires some input perturbation and data generation methods such as Pseudo-Random Binary Sequence (PRBS) inputs. By themselves, these methods are unsuitable for live cells as they can shock the system. To account for this, a suitable, intensified design of experiments (DOE) approach is used to perturb the data frequently enough to build a model of reasonable accuracy without significantly impacting live cells. This method is general enough to be used to identify appropriate input perturbation and data generation for many bioprocesses, and for our particular process of study it identified an input perturbation frequency of once per three days. The data-driven model is used in a model predictive control (MPC) scheme which respects biological constraints and can meet desired objectives. Further improvement in model robustness are made possible by incorporating first principles knowledge into the data-driven model. The methods are demonstrated on an advanced simulator developed by Sartorius with significant improvement over current industry standard. | en_US |
dc.language.iso | en_US | en_US |
dc.title | Data-Driven Modeling and Model Predictive Control of Monoclonal Antibody Process | en_US |
dc.type | Thesis | en_US |
dc.contributor.department | Chemical Engineering | en_US |
dc.description.degreetype | Thesis | en_US |
dc.description.degree | Master of Applied Science (MASc) | en_US |
dc.description.layabstract | Biopharma processes involving live cells are utilised to produce several critical products such as monoclonal antibodies which are state-of-the-art cancer therapeutics. Improving productivity for these would require advanced process control methods which in turn would require good models. This thesis focuses on introducing a method to build control relevant data driven models by using input perturbation and data generation suitable for live cell systems. The data driven model is utilised in a model predictive control scheme which meets control objectives while respecting biological constraints with better performance than industrial standards. Further improvement is made by incorporating first principles knowledge into the data driven model through a novel implementation of constrained subspace identification. The approaches are showcased on an advanced simulator test bed created by Sartorius. | en_US |
Appears in Collections: | Open Access Dissertations and Theses |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Sarna_Samardeepsingh_H_202208_MASc.pdf | 1.54 MB | Adobe PDF | View/Open |
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.